{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:16:04Z","timestamp":1792826164807,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["40-41900-98-018"],"award-info":[{"award-number":["40-41900-98-018"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008358","name":"Hersenstichting","doi-asserted-by":"publisher","award":["BG2013-03"],"award-info":[{"award-number":["BG2013-03"]}],"id":[{"id":"10.13039\/501100008358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007\u20132013"],"award-info":[{"award-number":["FP7\/2007\u20132013"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13024-018-0261-9","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T21:29:15Z","timestamp":1529616555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8414-7418","authenticated-orcid":false,"given":"Lodewijk J. A.","family":"Toonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Overzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin M.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia G.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander A. J.","family":"van der Zeeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szymon M.","family":"Kielbasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle J.","family":"Goeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M.","family":"Hettne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olafur Th.","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Poirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Seyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A. C.","family":"\u2018t Hoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willeke M. C.","family":"van Roon-Mom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"261_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12311-008-0013-4","volume":"7","author":"O Riess","year":"2008","unstructured":"Riess O, Rub U, Pastore A, Bauer P, Schols L. SCA3: neurological features, pathogenesis and animal models. Cerebellum. 2008;7:125\u201337.","journal-title":"Cerebellum"},{"key":"261_CR2","first-page":"1513","volume":"49","author":"MM Evers","year":"2014","unstructured":"Evers MM, Toonen LJ, van Roon-Mom WM. Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies. Mol Neurobiol. 2014;49:1513\u201331.","journal-title":"Mol Neurobiol"},{"key":"261_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pneurobio.2011.06.007","volume":"95","author":"CA Matos","year":"2011","unstructured":"Matos CA, de Macedo-Ribeiro S, Carvalho AL. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease. Prog Neurobiol. 2011;95:26\u201348.","journal-title":"Prog Neurobiol"},{"key":"261_CR4","doi-asserted-by":"publisher","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","volume":"27","author":"U Bichelmeier","year":"2007","unstructured":"Bichelmeier U, Schmidt T, Hubener J, Boy J, Ruttiger L, Habig K, Poths S, Bonin M, Knipper M, Schmidt WJ, et al. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J Neurosci. 2007;27:7418\u201328.","journal-title":"J Neurosci"},{"key":"261_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","volume":"19","author":"HL Paulson","year":"1997","unstructured":"Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel JL, Fischbeck KH, Pittman RN. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997;19:333\u201344.","journal-title":"Neuron"},{"key":"261_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/hmg\/8.4.673","volume":"8","author":"Y Chai","year":"1999","unstructured":"Chai Y, Koppenhafer SL, Shoesmith SJ, Perez MK, Paulson HL. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3\/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet. 1999;8:673\u201382.","journal-title":"Hum Mol Genet"},{"key":"261_CR7","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/jnr.22011","volume":"87","author":"YC Yu","year":"2009","unstructured":"Yu YC, Kuo CL, Cheng WL, Liu CS, Hsieh M. Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease. J Neurosci Res. 2009;87:1884\u201391.","journal-title":"J Neurosci Res"},{"key":"261_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.nbd.2008.03.011","volume":"31","author":"AH Chou","year":"2008","unstructured":"Chou AH, Yeh TH, Ouyang P, Chen YL, Chen SY, Wang HL. Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiol Dis. 2008;31:89\u2013101.","journal-title":"Neurobiol Dis"},{"key":"261_CR9","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1083\/jcb.143.6.1457","volume":"143","author":"MK Perez","year":"1998","unstructured":"Perez MK, Paulson HL, Pendse SJ, Saionz SJ, Bonini NM, Pittman RN. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol. 1998;143:1457\u201370.","journal-title":"J Cell Biol"},{"key":"261_CR10","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr","year":"2001","unstructured":"Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science (New York, NY). 2001;291:2423\u20138.","journal-title":"Science (New York, NY)"},{"key":"261_CR11","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1523\/JNEUROSCI.21-15-05389.2001","volume":"21","author":"BO Evert","year":"2001","unstructured":"Evert BO, Vogt IR, Kindermann C, Ozimek L, de Vos RA, Brunt ER, Schmitt I, Klockgether T, Wullner U. Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J Neurosci. 2001;21:5389\u201396.","journal-title":"J Neurosci"},{"key":"261_CR12","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/jnen\/62.10.1006","volume":"62","author":"BO Evert","year":"2003","unstructured":"Evert BO, Vogt IR, Vieira-Saecker AM, Ozimek L, de Vos RA, Brunt ER, Klockgether T, Wullner U. Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3. J Neuropathol Exp Neurol. 2003;62:1006\u201318.","journal-title":"J Neuropathol Exp Neurol"},{"key":"261_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/B978-0-12-384878-9.00012-1","volume":"100","author":"A Trancikova","year":"2011","unstructured":"Trancikova A, Ramonet D, Moore DJ. Genetic mouse models of neurodegenerative diseases. Prog Mol Biol Transl Sci. 2011;100:419\u201382.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"261_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11306-016-1084-8","volume":"12","author":"A Mastrokolias","year":"2016","unstructured":"Mastrokolias A, Pool R, Mina E, Hettne KM, van Duijn E, van der Mast RC, van Ommen G, t Hoen PA, Prehn C, Adamski J, van Roon-Mom W. Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington\u2019s disease peripheral blood samples. Metabolomics. 2016;12:137.","journal-title":"Metabolomics"},{"key":"261_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13023-016-0475-2","volume":"11","author":"E Mina","year":"2016","unstructured":"Mina E, van Roon-Mom W, Hettne K, van Zwet E, Goeman J, Neri C, ACtH P, Mons B, Roos M. Common disease signatures from gene expression analysis in Huntington\u2019s disease human blood and brain. Orphanet journal of rare diseases. 2016;11:97.","journal-title":"Orphanet journal of rare diseases"},{"key":"261_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/hmg\/11.9.1075","volume":"11","author":"CK Cemal","year":"2002","unstructured":"Cemal CK, Carroll CJ, Lawrence L, Lowrie MB, Ruddle P, Al-Mahdawi S, King RH, Pook MA, Huxley C, Chamberlain S. YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit. Hum Mol Genet. 2002;11:1075\u201394.","journal-title":"Hum Mol Genet"},{"key":"261_CR17","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41398-017-0042-1","volume":"7","author":"SL Gardiner","year":"2017","unstructured":"Gardiner SL, van Belzen MJ, Boogaard MW, van Roon-Mom WMC, Rozing MP, van Hemert AM, Smit JH, Beekman ATF, van Grootheest G, Schoevers RA, et al. Huntingtin gene repeat size variations affect risk of lifetime depression. Transl Psychiatry. 2017;7:1277.","journal-title":"Transl Psychiatry"},{"key":"261_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jchromb.2014.04.025","volume":"966","author":"S Boudah","year":"2014","unstructured":"Boudah S, Olivier MF, Aros-Calt S, Oliveira L, Fenaille F, Tabet JC, Junot C. Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;966:34\u201347.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"261_CR19","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"6","author":"WB Dunn","year":"2011","unstructured":"Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, Brown M, Knowles JD, Halsall A, Haselden JN, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6:1060\u201383.","journal-title":"Nat Protoc"},{"key":"261_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11306-016-1023-8","volume":"12","author":"A Seyer","year":"2016","unstructured":"Seyer A, Boudah S, Broudin S, Junot C, Colsch B. Annotation of the human cerebrospinal fluid lipidome using high resolution mass spectrometry and a dedicated data processing workflow. Metabolomics. 2016;12:91.","journal-title":"Metabolomics"},{"key":"261_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics (Oxford, England). 2013;29:15\u201321.","journal-title":"Bioinformatics (Oxford, England)"},{"key":"261_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (Oxford, England). 2010;26:139\u201340.","journal-title":"Bioinformatics (Oxford, England)"},{"key":"261_CR23","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11:R25.","journal-title":"Genome Biol"},{"key":"261_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/biostatistics\/kxr054","volume":"13","author":"KD Hansen","year":"2012","unstructured":"Hansen KD, Irizarry RA, Wu Z. Removing technical variability in RNA-seq data using conditional quantile normalization. Biostatistics (Oxford, England). 2012;13:204\u201316.","journal-title":"Biostatistics (Oxford, England)"},{"key":"261_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-98141-3","volume-title":"Book ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2009","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. In: Book ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag; 2009."},{"key":"261_CR26","unstructured":"Euretos platform. 2017. \n                    http:\/\/www.euretos.com\/\n                    \n                  ."},{"key":"261_CR27","unstructured":"Euretos platform databases. 2017. \n                    http:\/\/www.euretos.com\/files\/EKPSources2017.pdf\n                    \n                  ."},{"key":"261_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep35200","volume":"6","author":"LJ Toonen","year":"2016","unstructured":"Toonen LJ, Schmidt I, Luijsterburg MS, van Attikum H, van Roon-Mom WM. Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3. Sci Rep. 2016;6:35200.","journal-title":"Sci Rep"},{"key":"261_CR29","first-page":"365","volume":"132","author":"S Rozen","year":"2000","unstructured":"Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000;132:365\u201386.","journal-title":"Methods Mol Biol"},{"key":"261_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp045","volume":"37","author":"JM Ruijter","year":"2009","unstructured":"Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ, Moorman AF. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 2009;37:e45.","journal-title":"Nucleic Acids Res"},{"key":"261_CR31","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.biochem.68.1.821","volume":"68","author":"AJ Shaywitz","year":"1999","unstructured":"Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 1999;68:821\u201361.","journal-title":"Annu Rev Biochem"},{"key":"261_CR32","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","volume":"10","author":"A Wyttenbach","year":"2001","unstructured":"Wyttenbach A, Swartz J, Kita H, Thykjaer T, Carmichael J, Bradley J, Brown R, Maxwell M, Schapira A, Orntoft TF, et al. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington\u2019s disease. Hum Mol Genet. 2001;10:1829\u201345.","journal-title":"Hum Mol Genet"},{"key":"261_CR33","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1093\/hmg\/ddr351","volume":"20","author":"A Giralt","year":"2011","unstructured":"Giralt A, Saavedra A, Carreton O, Xifro X, Alberch J, Perez-Navarro E. Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington\u2019s disease. Hum Mol Genet. 2011;20:4232\u201347.","journal-title":"Hum Mol Genet"},{"key":"261_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1515\/rns.2011.018","volume":"22","author":"CA Saura","year":"2011","unstructured":"Saura CA, Valero J. The role of CREB signaling in Alzheimer\u2019s disease and other cognitive disorders. Rev Neurosci. 2011;22:153\u201369.","journal-title":"Rev Neurosci"},{"key":"261_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1152\/physrev.00017.2008","volume":"89","author":"CM Alberini","year":"2009","unstructured":"Alberini CM. Transcription factors in long-term memory and synaptic plasticity. Physiol Rev. 2009;89:121\u201345.","journal-title":"Physiol Rev"},{"key":"261_CR36","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.bbalip.2014.12.018","volume":"1851","author":"V Leoni","year":"2015","unstructured":"Leoni V, Caccia C. The impairment of cholesterol metabolism in Huntington disease. Biochim Biophys Acta. 2015;1851:1095\u2013105.","journal-title":"Biochim Biophys Acta"},{"key":"261_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","volume":"4","author":"RC Block","year":"2010","unstructured":"Block RC, Dorsey ER, Beck CA, Brenna JT, Shoulson I. Altered cholesterol and fatty acid metabolism in Huntington disease. J Clin Lipidol. 2010;4:17\u201323.","journal-title":"J Clin Lipidol"},{"key":"261_CR38","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","volume":"32","author":"G Bartzokis","year":"2007","unstructured":"Bartzokis G, Lu PH, Tishler TA, Fong SM, Oluwadara B, Finn JP, Huang D, Bordelon Y, Mintz J, Perlman S. Myelin breakdown and iron changes in Huntington\u2019s disease: pathogenesis and treatment implications. Neurochem Res. 2007;32:1655\u201364.","journal-title":"Neurochem Res"},{"key":"261_CR39","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/ana.410400514","volume":"40","author":"K Nishiyama","year":"1996","unstructured":"Nishiyama K, Murayama S, Goto J, Watanabe M, Hashida H, Katayama S, Nomura Y, Nakamura S, Kanazawa I. Regional and cellular expression of the Machado-Joseph disease gene in brains of normal and affected individuals. Ann Neurol. 1996;40:776\u201381.","journal-title":"Ann Neurol"},{"key":"261_CR40","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.neuron.2016.02.011","volume":"89","author":"M Ingram","year":"2016","unstructured":"Ingram M, Wozniak EA, Duvick L, Yang R, Bergmann P, Carson R, O\u2019Callaghan B, Zoghbi HY, Henzler C, Orr HT. Cerebellar transcriptome profiles of ATXN1 transgenic mice reveal SCA1 disease progression and protection pathways. Neuron. 2016;89:1194\u2013207.","journal-title":"Neuron"},{"key":"261_CR41","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1093\/hmg\/ddh268","volume":"13","author":"HG Serra","year":"2004","unstructured":"Serra HG, Byam CE, Lande JD, Tousey SK, Zoghbi HY, Orr HT. Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. Hum Mol Genet. 2004;13:2535\u201343.","journal-title":"Hum Mol Genet"},{"key":"261_CR42","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.neuint.2009.11.003","volume":"56","author":"AH Chou","year":"2010","unstructured":"Chou AH, Chen CY, Chen SY, Chen WJ, Chen YL, Weng YS, Wang HL. Polyglutamine-expanded ataxin-7 causes cerebellar dysfunction by inducing transcriptional dysregulation. Neurochem Int. 2010;56:329\u201339.","journal-title":"Neurochem Int"},{"key":"261_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks001","volume":"40","author":"Y Benjamini","year":"2012","unstructured":"Benjamini Y, Speed TP. Summarizing and correcting the GC content bias in high-throughput sequencing. Nucleic Acids Res. 2012;40:e72.","journal-title":"Nucleic Acids Res"},{"key":"261_CR44","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/mds.26238","volume":"30","author":"M Raposo","year":"2015","unstructured":"Raposo M, Bettencourt C, Maciel P, Gao F, Ramos A, Kazachkova N, Vasconcelos J, Kay T, Rodrigues AJ, Bettencourt B, et al. Novel candidate blood-based transcriptional biomarkers of Machado-Joseph disease. Move Disord. 2015;30:968\u201375.","journal-title":"Move Disord"},{"key":"261_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0891-5849(02)00879-1","volume":"33","author":"U Denis","year":"2002","unstructured":"Denis U, Lecomte M, Paget C, Ruggiero D, Wiernsperger N, Lagarde M. Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol\/ceramide production and oxidative stress induction. Free Radic Biol Med. 2002;33:236\u201347.","journal-title":"Free Radic Biol Med"},{"key":"261_CR46","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/sj.leu.2402197","volume":"15","author":"PP Ruvolo","year":"2001","unstructured":"Ruvolo PP. Ceramide regulates cellular homeostasis via diverse stress signaling pathways. Leukemia. 2001;15:1153\u201360.","journal-title":"Leukemia"},{"key":"261_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1089\/omi.2016.0106","volume":"20","author":"M Kori","year":"2016","unstructured":"Kori M, Aydin B, Unal S, Arga KY, Kazan D. Metabolic biomarkers and neurodegeneration: a pathway enrichment analysis of Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis. Omics. 2016;20:645\u201361.","journal-title":"Omics"},{"key":"261_CR48","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/ejhg.2014.281","volume":"23","author":"A Mastrokolias","year":"2015","unstructured":"Mastrokolias A, Ariyurek Y, Goeman JJ, van Duijn E, Roos RA, van der Mast RC, van Ommen GB, den Dunnen JT, t Hoen PA, van Roon-Mom WM. Huntington\u2019s disease biomarker progression profile identified by transcriptome sequencing in peripheral blood. Eur J Human Genetics. 2015;23:1349\u201356.","journal-title":"Eur J Human Genetics"},{"key":"261_CR49","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","volume":"359","author":"CM Chen","year":"2007","unstructured":"Chen CM, Wu YR, Cheng ML, Liu JL, Lee YM, Lee PW, Soong BW, Chiu DT. Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington\u2019s disease patients. Biochem Biophys Res Commun. 2007;359:335\u201340.","journal-title":"Biochem Biophys Res Commun"},{"key":"261_CR50","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000339207","volume":"11","author":"N Kazachkova","year":"2013","unstructured":"Kazachkova N, Raposo M, Montiel R, Cymbron T, Bettencourt C, Silva-Fernandes A, Silva S, Maciel P, Lima M. Patterns of mitochondrial DNA damage in blood and brain tissues of a transgenic mouse model of Machado-Joseph disease. Neurodegener Dis. 2013;11:206\u201314.","journal-title":"Neurodegener Dis"},{"key":"261_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2016.09.002","volume":"96","author":"NE Sen","year":"2016","unstructured":"Sen NE, Drost J, Gispert S, Torres-Odio S, Damrath E, Klinkenberg M, Hamzeiy H, Akdal G, Gulluoglu H, Basak AN, Auburger G. Search for SCA2 blood RNA biomarkers highlights Ataxin-2 as strong modifier of the mitochondrial factor PINK1 levels. Neurobiol Dis. 2016;96:115\u201326.","journal-title":"Neurobiol Dis"},{"key":"261_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1471-4159.2009.06442.x","volume":"112","author":"CM Forrest","year":"2010","unstructured":"Forrest CM, Mackay GM, Stoy N, Spiden SL, Taylor R, Stone TW, Darlington LG. Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington\u2019s disease. J Neurochem. 2010;112:112\u201322.","journal-title":"J Neurochem"},{"key":"261_CR53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-1-4615-4709-9_19","volume":"467","author":"B Widner","year":"1999","unstructured":"Widner B, Leblhuber F, Walli J, Tilz GP, Demel U, Fuchs D. Degradation of tryptophan in neurodegenerative disorders. Adv Exp Med Biol. 1999;467:133\u20138.","journal-title":"Adv Exp Med Biol"},{"key":"261_CR54","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1073\/pnas.85.11.4079","volume":"85","author":"R Schwarcz","year":"1988","unstructured":"Schwarcz R, Okuno E, White RJ, Bird ED, Whetsell WO Jr. 3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims. Proc Natl Acad Sci U S A. 1988;85:4079\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"261_CR55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.mrgentox.2013.06.023","volume":"757","author":"LS Pacheco","year":"2013","unstructured":"Pacheco LS, da Silveira AF, Trott A, Houenou LJ, Algarve TD, Bello C, Lenz AF, Manica-Cattani MF, da Cruz IB. Association between Machado-Joseph disease and oxidative stress biomarkers. Mutat Res. 2013;757:99\u2013103.","journal-title":"Mutat Res"},{"key":"261_CR56","doi-asserted-by":"publisher","first-page":"21204","DOI":"10.1074\/jbc.M111.321661","volume":"287","author":"N Zhang","year":"2012","unstructured":"Zhang N, Li B, Al-Ramahi I, Cong X, Held JM, Kim E, Botas J, Gibson BW, Ellerby LM. Inhibition of lipid signaling enzyme diacylglycerol kinase epsilon attenuates mutant huntingtin toxicity. J Biol Chem. 2012;287:21204\u201313.","journal-title":"J Biol Chem"},{"key":"261_CR57","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-4020-8831-5_9","volume":"49","author":"RM Adibhatla","year":"2008","unstructured":"Adibhatla RM, Hatcher JF. Altered lipid metabolism in brain injury and disorders. Subcell Biochem. 2008;49:241\u201368.","journal-title":"Subcell Biochem"},{"key":"261_CR58","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.brainresrev.2008.10.001","volume":"59","author":"G Arboleda","year":"2009","unstructured":"Arboleda G, Morales LC, Benitez B, Arboleda H. Regulation of ceramide-induced neuronal death: cell metabolism meets neurodegeneration. Brain Res Rev. 2009;59:333\u201346.","journal-title":"Brain Res Rev"},{"key":"261_CR59","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.bbamem.2006.09.018","volume":"1758","author":"EI Posse de Chaves","year":"2006","unstructured":"Posse de Chaves EI. Sphingolipids in apoptosis, survival and regeneration in the nervous system. Biochim Biophys Acta. 2006;1758:1995\u20132015.","journal-title":"Biochim Biophys Acta"},{"key":"261_CR60","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ana.10312","volume":"52","author":"RG Cutler","year":"2002","unstructured":"Cutler RG, Pedersen WA, Camandola S, Rothstein JD, Mattson MP. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol. 2002;52:448\u201357.","journal-title":"Ann Neurol"},{"key":"261_CR61","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/B978-0-12-801022-8.00010-6","volume":"119","author":"CF Lee","year":"2014","unstructured":"Lee CF, Chern Y. Adenosine receptors and Huntington\u2019s disease. Int Rev Neurobiol. 2014;119:195\u2013232.","journal-title":"Int Rev Neurobiol"},{"key":"261_CR62","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuropharm.2015.08.009","volume":"99","author":"AH Chou","year":"2015","unstructured":"Chou AH, Chen YL, Chiu CC, Yuan SJ, Weng YH, Yeh TH, Lin YL, Fang JM, Wang HL. T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse. Neuropharmacology. 2015;99:308\u201317.","journal-title":"Neuropharmacology"},{"key":"261_CR63","doi-asserted-by":"publisher","first-page":"45004","DOI":"10.1074\/jbc.M205259200","volume":"277","author":"F Li","year":"2002","unstructured":"Li F, Macfarlan T, Pittman RN, Chakravarti D. Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J Biol Chem. 2002;277:45004\u201312.","journal-title":"J Biol Chem"},{"key":"261_CR64","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","volume":"9","author":"A McCampbell","year":"2000","unstructured":"McCampbell A, Taylor JP, Taye AA, Robitschek J, Li M, Walcott J, Merry D, Chai Y, Paulson H, Sobue G, Fischbeck KH. CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet. 2000;9:2197\u2013202.","journal-title":"Hum Mol Genet"},{"key":"261_CR65","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1471-4159.2005.03060.x","volume":"93","author":"M Shimohata","year":"2005","unstructured":"Shimohata M, Shimohata T, Igarashi S, Naruse S, Tsuji S. Interference of CREB-dependent transcriptional activation by expanded polyglutamine stretches--augmentation of transcriptional activation as a potential therapeutic strategy for polyglutamine diseases. J Neurochem. 2005;93:654\u201363.","journal-title":"J Neurochem"},{"key":"261_CR66","doi-asserted-by":"publisher","first-page":"10261","DOI":"10.1073\/pnas.0503937102","volume":"102","author":"K Iijima-Ando","year":"2005","unstructured":"Iijima-Ando K, Wu P, Drier EA, Iijima K, Yin JC. cAMP-response element-binding protein and heat-shock protein 70 additively suppress polyglutamine-mediated toxicity in Drosophila. Proc Natl Acad Sci U S A. 2005;102:10261\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"261_CR67","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/370223a0","volume":"370","author":"RP Kwok","year":"1994","unstructured":"Kwok RP, Lundblad JR, Chrivia JC, Richards JP, Bachinger HP, Brennan RG, Roberts SG, Green MR, Goodman RH. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 1994;370:223\u20136.","journal-title":"Nature"},{"key":"261_CR68","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1101\/gad.10.22.2903","volume":"10","author":"JD Oliner","year":"1996","unstructured":"Oliner JD, Andresen JM, Hansen SK, Zhou S, Tjian R. SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. Genes Dev. 1996;10:2903\u201311.","journal-title":"Genes Dev"},{"key":"261_CR69","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM. The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A. 2000;97:6763\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"261_CR70","doi-asserted-by":"publisher","first-page":"13002","DOI":"10.1523\/JNEUROSCI.2789-11.2011","volume":"31","author":"VG Shakkottai","year":"2011","unstructured":"Shakkottai VG, do Carmo Costa M, Dell\u2019Orco JM, Sankaranarayanan A, Wulff H, Paulson HL. Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3. J Neurosci. 2011;31:13002\u201314.","journal-title":"J Neurosci"},{"key":"261_CR71","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/mt.2013.144","volume":"21","author":"C Costa Mdo","year":"2013","unstructured":"Costa Mdo C, Luna-Cancalon K, Fischer S, Ashraf NS, Ouyang M, Dharia RM, Martin-Fishman L, Yang Y, Shakkottai VG, Davidson BL, et al. Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease. Mol Therapy. 2013;21:1898\u2013908.","journal-title":"Mol Therapy"},{"key":"261_CR72","doi-asserted-by":"publisher","first-page":"12713","DOI":"10.1523\/JNEUROSCI.3909-08.2008","volume":"28","author":"X Chen","year":"2008","unstructured":"Chen X, Tang TS, Tu H, Nelson O, Pook M, Hammer R, Nukina N, Bezprozvanny I. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3. J Neurosci. 2008;28:12713\u201324.","journal-title":"J Neurosci"},{"key":"261_CR73","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.omtn.2017.06.019","volume":"8","author":"LJA Toonen","year":"2017","unstructured":"Toonen LJA, Rigo F, van Attikum H, van Roon-Mom WMC. Antisense oligonucleotide-mediated removal of the Polyglutamine repeat in spinocerebellar Ataxia type 3 mice. Mol Ther Nucleic Acids. 2017;8:232\u201342.","journal-title":"Mol Ther Nucleic Acids"},{"key":"261_CR74","doi-asserted-by":"publisher","first-page":"e0175468","DOI":"10.1371\/journal.pone.0175468","volume":"12","author":"LJ Moore","year":"2017","unstructured":"Moore LJ, Nilsen TO, Jarungsriapisit J, Fjelldal PG, Stefansson SO, Taranger GL, Patel S. Triploid atlantic salmon (Salmo salar L.) post-smolts accumulate prevalence more slowly than diploid salmon following bath challenge with salmonid alphavirus subtype 3. PLoS One. 2017;12:e0175468.","journal-title":"PLoS One"},{"key":"261_CR75","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1750-3639.1998.tb00193.x","volume":"8","author":"T Schmidt","year":"1998","unstructured":"Schmidt T, Landwehrmeyer GB, Schmitt I, Trottier Y, Auburger G, Laccone F, Klockgether T, Volpel M, Epplen JT, Schols L, Riess O. An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients. Brain Pathol (Zurich, Switzerland). 1998;8:669\u201379.","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"key":"261_CR76","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1001\/archneur.62.8.1280","volume":"62","author":"U Wullner","year":"2005","unstructured":"Wullner U, Reimold M, Abele M, Burk K, Minnerop M, Dohmen BM, Machulla HJ, Bares R, Klockgether T. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6. Arch Neurol. 2005;62:1280\u20135.","journal-title":"Arch Neurol"},{"key":"261_CR77","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev.neuro.23.1.185","volume":"23","author":"SM Nicola","year":"2000","unstructured":"Nicola SM, Surmeier J, Malenka RC. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci. 2000;23:185\u2013215.","journal-title":"Annu Rev Neurosci"},{"key":"261_CR78","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.neuron.2012.03.017","volume":"74","author":"M Watabe-Uchida","year":"2012","unstructured":"Watabe-Uchida M, Zhu L, Ogawa SK, Vamanrao A, Uchida N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron. 2012;74:858\u201373.","journal-title":"Neuron"},{"key":"261_CR79","doi-asserted-by":"publisher","first-page":"9930","DOI":"10.1523\/JNEUROSCI.21-24-09930.2001","volume":"21","author":"M Andersson","year":"2001","unstructured":"Andersson M, Konradi C, Cenci MA. cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. J Neurosci. 2001;21:9930\u201343.","journal-title":"J Neurosci"},{"key":"261_CR80","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/hmg\/ddx191","volume":"26","author":"LT Pflieger","year":"2017","unstructured":"Pflieger LT, Dansithong W, Paul S, Scoles DR, Figueroa KP, Meera P, Otis TS, Facelli JC, Pulst SM. Gene co-expression network analysis for identifying modules and functionally enriched pathways in SCA2. Hum Mol Genet. 2017;26:3069\u201380.","journal-title":"Hum Mol Genet"},{"key":"261_CR81","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1093\/hmg\/ddx224","volume":"26","author":"B Ramani","year":"2017","unstructured":"Ramani B, Panwar B, Moore LR, Wang B, Huang R, Guan Y, Paulson HL. Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes. Hum Mol Genet. 2017;26:3362\u201374.","journal-title":"Hum Mol Genet"},{"key":"261_CR82","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/01.jnen.0000225905.52002.3e","volume":"65","author":"E Kida","year":"2006","unstructured":"Kida E, Palminiello S, Golabek AA, Walus M, Wierzba-Bobrowicz T, Rabe A, Albertini G, Wisniewski KE. Carbonic anhydrase II in the developing and adult human brain. J Neuropathol Exp Neurol. 2006;65:664\u201374.","journal-title":"J Neuropathol Exp Neurol"},{"key":"261_CR83","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/jnr.490400404","volume":"40","author":"W Cammer","year":"1995","unstructured":"Cammer W, Zhang H, Tansey FA. Effects of carbonic anhydrase II (CAII) deficiency on CNS structure and function in the myelin-deficient CAII-deficient double mutant mouse. J Neurosci Res. 1995;40:451\u20137.","journal-title":"J Neurosci Res"},{"key":"261_CR84","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/jnr.490230208","volume":"23","author":"MS Ghandour","year":"1989","unstructured":"Ghandour MS, Skoff RP, Venta PJ, Tashian RE. Oligodendrocytes express a normal phenotype in carbonic anhydrase II-deficient mice. J Neurosci Res. 1989;23:180\u201390.","journal-title":"J Neurosci Res"},{"key":"261_CR85","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/srep00002","volume":"1","author":"MM Soundarapandian","year":"2011","unstructured":"Soundarapandian MM, Selvaraj V, Lo UG, Golub MS, Feldman DH, Pleasure DE, Deng W. Zfp488 promotes oligodendrocyte differentiation of neural progenitor cells in adult mice after demyelination. Sci Rep. 2011;1:2.","journal-title":"Sci Rep"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-018-0261-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13024-018-0261-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-018-0261-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T19:46:33Z","timestamp":1569354393000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-018-0261-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["261"],"URL":"https:\/\/doi.org\/10.1186\/s13024-018-0261-9","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]},"assertion":[{"value":"29 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Leiden University animal ethical committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Kristina M. Hettne has performed paid consultancy since November 1, 2015, for Euretos b.v, a startup founded in 2012 that develops knowledge management and discovery services for the life sciences, with the Euretos Knowledge Platform as a marketed product.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"31"}}